Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added revision note v3.4.3 and removed v3.4.2 from the page.
    Difference
    0.0%
    Check dated 2026-03-07T15:21:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the former v3.4.1. This update does not modify the study content or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-02-14T04:12:22.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. This is a minor version update and does not affect study content, eligibility criteria, outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T02:11:50.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    UI and text updates include adding a glossary toggle (Show/Hide glossary), adjusting the QC criterion label from previous wording to a new one, and adding 'No FEAR Act Data' and 'Revision: v3.4.0' notes. These changes do not affect the study content or critical study information.
    Difference
    0.1%
    Check dated 2026-01-23T18:32:38.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-16T12:29:21.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The Locations section was updated with a large number of new trial sites across multiple countries (US, Canada, Europe, Asia, Australia, and South America), expanding where patients may enroll. At the same time, many existing locations were removed, indicating a restructuring of site availability.
    Difference
    4%
    Check dated 2025-12-19T05:40:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.